Ju-In Eom

1k citations
20 papers · 819 · h-index 15

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • PI3K/AKT/mTOR signaling in cancer
    • Protein Kinase Regulation and GTPase Signaling
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Cell death mechanisms and regulation

Papers in

    • Acute Myeloid Leukemia Research 13
    • Sesquiterpenes and Asteraceae Studies 2
    • MicroRNA in disease regulation 1

Ju-In Eom

20 papers receiving 806 citations

Peers

Ju-In Eom
Comparison fields: 5 of 56
  • Hematology 214
  • Molecular Biology 327
  • Cancer Research 57
  • Epidemiology 112
  • Oncology 70
Replace Lisa Crawford with:
Lisa Crawford United Kingdom
Bai-Wei Gu China
Élodie Richard France
Janet L. Anderl United States
Nina Kurrle Germany
Courteney K. Lai Canada
Kristina A. West United States
Dariush Farahi Far France
Anthony L. Sinn United States
Derek Mendy United States
Ju-In Eom relative to Lisa Crawford United Kingdom Lisa Crawford's profile →
Citations per field
00.5×1.5×2.0×
Lisa Crawford · 1×
Citations per year

Countries citing papers authored by Ju-In Eom

Since Specialization
Citations

This map shows the geographic impact of Ju-In Eom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-In Eom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-In Eom more than expected).

Fields of papers citing papers by Ju-In Eom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-In Eom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-In Eom. The network helps show where Ju-In Eom may publish in the future.

Co-authors

The 25 scholars most cited alongside Ju-In Eom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ju-In Eom Line = papers co-authored together Ju-In Eom links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2007168
2 2016114
3 200482
4 200375
5
Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
200366
6 202053
7 201037
8 200336
9 202033
10 201429
11 201529
12 201618
13 201217
14 202117
15 201916
16 201013
17 202312
18 20142
19 20071
20 20081

About Ju-In Eom

Ju-In Eom is a scholar working on Hematology, Cancer Research, Epidemiology, Molecular Biology and Cell Biology, having authored 20 papers that have together received 819 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Cell death mechanisms and regulation (4 papers), Autophagy in Disease and Therapy (4 papers), Sesquiterpenes and Asteraceae Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper), Microtubule and mitosis dynamics (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hematology (214 citations), Molecular Biology (327 citations), Cancer Research (57 citations), Epidemiology (112 citations) and Oncology (70 citations). Ju-In Eom has collaborated with scholars based in South Korea. Frequent co-authors include June‐Won Cheong, Yoo Hong Min, Jin Seok Kim, Hoi-Kyung Jeung, Ji Eun Jang, Seung‐Tae Lee, Jee Sook Hahn, Yun Woong Ko, Jin-Ku Lee and Woo Ick Yang. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Experimental & Clinical Cancer Research, Leukemia Research and Experimental Hematology and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact